FMO5 and systemic sclerosis: Skin changes typical for lc‐SSc and dc‐SSc have been induced in vivo by the intradermal injection of ROS‐generating compounds.10, 11, 12 In addition, targeting of ROS‐generating NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.13